MyFastRx review

A quarter dose costs exactly what a full dose costs here, and MyFastRx is more explicit about it than anyone — same price at any dose, no dose-stage upcharges, from week one through month six and beyond, plus a second statement that approved dose changes carry no extra cost. If you are taking less to spend less, that is the shape working against you, and the gap is drug you buy and never use. Credit where it is earned. It labels its prepay figures as equivalents and says the money is taken up front, rather than passing a prepay rate off as a monthly price. It offers a genuinely non-recurring single month. And it discloses that the introductory price needs a code and is new-customers-only. Two things still cost you. The figure in the nav is that first month, and the rate that recurs is about double it. And no milligram figure sits behind any price.

Vs median

$36/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

MyFastRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

MyFastRx sells compounded semaglutide and compounded tirzepatide as weekly injections, priced openly with a standing monthly rate, a coded first-month price and a semaglutide prepay ladder. It states its flat-dose policy twice, once naming the specific practice it rules out and once confirming that approved dose changes carry no extra cost. Prepay figures are labeled "/mo equivalent" and "billed upfront" rather than presented as monthly rates, and a single-month option carries no subscription behind it. No compounding pharmacy is named and no milligram figure appears against any price.

ONE PRICE AT EVERY DOSE IS THE STRUCTURE THIS SITE EXISTS TO FLAG. "Same price at any dose... no dose-stage upcharges" means a patient deliberately holding a quarter dose pays the identical $139 as one at the top of the range

• THE "FROM $69" IN THE NAV IS THE FIRST MONTH ONLY, requires code MY70 and is new-customers-only; the standing rate is $139/mo, disclosed on the same card as "Then $139/mo"
• NO MILLIGRAM FIGURE IS PUBLISHED AGAINST ANY PRICE, so the flat promise cannot be checked against a dose range
• The prepay rungs take the whole sum in one charge — $948 for the 12-month plan, labeled "billed upfront"
• No tirzepatide prepay ladder is published on the semaglutide page
• No compounding pharmacy is named
• States served are not published
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

MyFastRx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan